White Plains, NY, United States of America

Anindita Ganguly

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anindita Ganguly: Innovator in Heart Failure Treatment

Introduction

Anindita Ganguly is a notable inventor based in White Plains, NY (US), recognized for her contributions to medical innovations. With a total of three patents to her name, she has made significant strides in the field of heart failure treatment.

Latest Patents

One of her latest patents focuses on the therapeutic dosing of a neuregulin or a subsequence thereof for the treatment or prophylaxis of heart failure. This invention is directed towards establishing a dosing regimen that maintains and enhances the therapeutic benefits of administering a neuregulin, such as glial growth factor 2 (GGF2), while minimizing potential side effects. This innovative approach aims to improve the quality of life for mammals suffering from heart failure.

Career Highlights

Anindita Ganguly is currently associated with Acorda Therapeutics, Inc., where she continues to develop groundbreaking treatments. Her work is pivotal in advancing therapeutic options for heart failure, showcasing her dedication to improving patient outcomes.

Collaborations

Anindita collaborates with esteemed colleagues, including Anthony O Caggiano and Jennifer Iaci, who contribute to her innovative projects and research endeavors.

Conclusion

Anindita Ganguly's work in the field of heart failure treatment exemplifies her commitment to medical innovation. Her patents and collaborations highlight her significant impact on healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…